Human stem cells prevent flap necrosis in preclinical animal models: A systematic review
Background and Aim: Adipose-derived mesenchymal stem cells (ADSCs) have been proven effective to prevent distal skin flap necrosis in preclinical models. However, to appropriately translate these findings to clinical trials, the effect of ADSC of human origin (hADSC) needs to be evaluated. We hypothesize that hADSC treatment is as effective as animal ADSC treatment at preventing distal skin flap necrosis in animal flap models.
Methods: Three databases were inquired on August 17, 2020, to evaluate the necrotic flap area after using hADSCs in animal models of ischemic flaps. No publication status or dates were considered. Studies were included if they used hADSCs, measured the surviving or necrotic skin area of flaps, used animal models, and were in English. Studies were excluded if they did not use cells of human origin. The flap survival or necrotic area, perfusion, capillary density, vascular endothelial growth factor secretion and HIF-1α expression were extracted.
Results: Ten studies met inclusion criteria. The mean absolute risk reduction (ARR) in necrotic skin area was 22.37% (95% confidence interval [CI] 16.98-27.76%, P<0.05) for flaps treated with animal ADSCs and 18.04% (95% CI 2.74-33.33%, P<0.05) for flaps treated with hADSCs. The difference between mean ARRs was not statistically significant (4.33%, 95% CI – 34.47-43.13%, P>0.05).
Conclusion: Human ADSCs prevent skin flap necrosis to the same degree as animal ADSCs in rodent and rabbit flap models.
Relevance for Patients: This review found that adipose-derived stem cells of human origin are equally effective at reducing the risk of surgical flap necrosis in preclinical models of small animals as autologous animal cells. The findings in this review should encourage researchers to use human adipose-derived stem cells in animal models of ischemic flaps to accelerate their translation into clinical trials and, eventually, surgical practice. The low immunogenicity of these cells should be leveraged to gain insight into the effects of the products that will be ultimately administered to patients. Furthermore, human adipose-derived stem cells’ pro-angiogenic mechanism of action sets this therapy as a promising preventive measure for flap necrosis.
[1] Pang CY, Forrest CR, Morris SF. Pharmacological Augmentation of Skin Flap Viability: A Hypothesis to
Mimic the Surgical Delay Phenomenon or a Wishful Thought. Ann Plast Surg 1989;22:293-306.
[2] Campos JH, Gomes HC, dos Santos WL, Cardeal M, Ferreira LM. Effect of Nicotine Treatment and Withdrawal on Random-Pattern Skin Flaps in Rats. Exp Toxicol Pathol 2008;60:449-52.
[3] Matsumura H, Yoshizawa N, Watanabe K, Vedder NB. Preconditioning of the Distal Portion of a Rat Randompattern Skin Flap. Br J Plast Surg 2001;54:58-61.
[4] Kwok AC, Agarwal JP. An Analysis of Free Flap Failure Using the ACS NSQIP Database. Does Flap Site and Flap Type Matter? Microsurgery 2017;37:531-8.
[5] Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, et al. Skin flap Necrosis after Mastectomy
with Reconstruction: A Prospective Study. Ann Surg Oncol 2016;23:257-64.
[6] Reintgen C, Leavitt A, Pace E, Molas-Pierson J, Mast BA. Risk Factor Analysis for Mastectomy Skin Flap Necrosis: Implications for Intraoperative Vascular Analysis. Ann Plast Surg 2016;76 Suppl 4:S336-9.
[7] Rao R, Saint-Cyr M, Ma AM, Bowling M, Hatef DA, Andrews V, et al. Prediction of Post-operative Necrosis
after Mastectomy: APilot Study Utilizing Optical Diffusion Imaging Spectroscopy. World J Surg Oncol 2009;7:91.
[8] Davis RE, Wachholz JH, Jassir D, Perlyn CA, Agrama MH. Comparison of Topical Anti-ischemic Agents in the Salvage of Failing Random-pattern Skin Flaps in Rats. Arch Facial Plast Surg 1999;1:27-32.
[9] Afraz S, Kamran A, Moazzami K, Nezami BG, Dehpour AR. Protective Effect of Pharmacologic Preconditioning with Pioglitazone on Random-pattern Skin Flap in Rat is Mediated by Nitric Oxide System. J Surg Res 2012;176:696-700.
[10] Mounsey RA, Pang CY, Forrest C. Preconditioning: A New Technique For Improved Muscle Flap Survival.
Otolaryngol Head Neck Surg 1992;107:549-552.
[11] Hamilton K, Wolfswinkel EM, Weathers WM, Xue AS, Hatef DA, Izaddoost S, et al. The Delay Phenomenon:
A Compilation of Knowledge across Specialties. Craniomaxillofac Trauma Reconstr 2014;7:112-8.
[12] Murry CE, Jennings RB, Reimer KA. Preconditioning with Ischemia: A Delay of Lethal Cell Injury in Ischemic
Myocardium. Circulation 1986;74:1124-36.
[13] Huemer GM, Froschauer SM, Pachinger T, Kwasny O, Schoffl H. A Comparison of Pretreatment with a Topical Combination of Nonivamide and Nicoboxil and Surgical Delay in a Random Pattern Skin Flap Model. J Plast Reconstr Aesthet Surg 2009;62:914-9.
[14] Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The Effects of VEGF on Survival of a
Random Flap in the Rat: Examination of Various Routes of Administration. Br J Plast Surg 2000;53:234-9.
[15] Gurunluoglu R, Meirer R, Shafighi M, Huemer GM, Yilmaz B, Piza-Katzer H. Gene Therapy with Adenovirusmediated VEGF Enhances Skin Flap Prefabrication. Microsurgery 2005;25:433-41.
[16] Huemer GM, Shafighi M, Meirer R, Debagge P, PizaKatzer H, Gurunluoglu R. Adenovirus-mediated
Transforming Growth Factor-beta Ameliorates Ischemic Necrosis of Epigastric Skin Flaps in a Rat Model. J Surg
Res 2004;121:101-7.
[17] Shafighi M, Olariu R, Fathi AR, etal. Dimethyloxalylglycine Stabilizes HIF-1α in Cultured Human Endothelial Cells and Increases Random-pattern Skin Flap Survival In Vivo. Plast Reconstr Surg 2011;128:415-22.
[18] Cai Y, Yu Z, Yu Q, et al. Fat Extract Improves Random Pattern Skin Flap Survival in a Rat Model. Aesthet Surg J 2019;39:NP504-14.
[19] Zhao L, Johnson T, Liu D. Therapeutic Angiogenesis of Adipose-derived Stem Cells for Ischemic Diseases. Stem Cell Res Ther 2017;8:125.
[20] Blackshear CP, Borrelli MR, Shen EZ, Ransom RC, Chung NN, Vistnes SM, et al. Utilizing Confocal
Microscopy to Characterize Human and Mouse Adipose Tissue. Tissue Eng Part C Methods 2018;24:566-77.
[21] Nahar S, Nakashima Y, Miyagi-Shiohira C, Kinjo T, Kobayashi N, Saitoh I, et al. A Comparison of Proteins
Expressed between Human and Mouse Adipose-Derived Mesenchymal Stem Cells by a Proteome Analysis through Liquid Chromatography with Tandem Mass Spectrometry. Int J Mol Sci 2018;19:3497.
[22] Zomer HD, Roballo KC, Lessa TB, Bressan FF, Gonçalves NN, Meirelles FV, et al. Distinct Features of
Rabbit and Human Adipose-derived Mesenchymal Stem Cells: Implications for Biotechnology and Translational
Research. Stem Cells Cloning 2018;11:43-54.
[23] Dosier CR, Erdman CP, Park JH, Schwartz Z, Boyan BD, Guldberg RE. Resveratrol Effect on Osteogenic
Differentiation of Rat and Human Adipose Derived Stem Cells in a 3-D Culture Environment. J Mech Behav Biomed Mater 2012;11:112-22.
[24] Patrikoski M, Mannerström B, Miettinen S. Perspectives for Clinical Translation of Adipose Stromal/Stem Cells. Stem Cells Int 2019;2019:5858247.
[25] Ten Sande JN, Smit NW, Parvizi M, van Amersfoorth SC, Plantinga JA, van Dessel PF, et al. Differential Mechanisms of Myocardial Conduction Slowing by Adipose TissueDerived Stromal Cells Derived from Different Species. Stem Cells Transl Med 2017;6:22-30.
[26] Foroglou P, Karathanasis V, Demiri E, Koliakos G, Papadakis M. Role of Adipose-derived Stromal Cells
in Pedicle Skin Flap Survival in Experimental Animal Models. World J Stem Cells 2016;8:101-5.
[27] Rasmussen JG, Frøbert O, Holst-Hansen C, Kastrup J, Baandrup U, Zachar V, et al. Comparison of Human
Adipose-derived Stem Cells and Bone Marrow-derived Stem Cells in a Myocardial Infarction Model. Cell
Transplant 2014;23:195-206.
[28] Schweizer R, Waldner M, Oksuz S, Zhang W, Komatsu C, Plock JA, et al. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy. Front Immunol 2020;11:826.
[29] Pu CM, Liu CW, Liang CJ, Yen YH, Chen SH, JiangShieh YF, et al. Adipose-Derived Stem Cells Protect
Skin Flaps against Ischemia/Reperfusion Injury via IL-6 Expression. J Invest Dermatol 2017;137:1353-62.
[30] Feng CJ, Perng CK, Lin CH, Tsai CH, Huang PH, Ma H. Intra-arterial Injection of Human Adipose-derived Stem Cells Improves Viability of the Random Component of Axial Skin Flaps in Nude Mice. J Plast Reconstr Aesthet Surg 2020;73:598-607.
[31] McFarlane RM, Deyoung G, Henry RA. The Design of a Pedicle Flap in the Rat to Study Necrosis And Its
Prevention. Plast Reconstr Surg 1965;35:177-82.
[32] Gong L, Wang C, Li Y, Sun Q, Li G, Wang D. Effects of Human Adipose-Derived Stem Cells on the Viability of Rabbit Random Pattern Flaps. Cytotherapy 2014;16:496-507.
[33] Gao W, Qiao X, Ma S, Cui L. Adipose-derived Stem Cells Accelerate Neovascularization in Ischaemic Diabetic Skin Flap via Expression of Hypoxia-Inducible Factor-1α. J Cell Mol Med 2011;15:2575-85.
[34] Lee DW, Jeon YR, Cho EJ, Kang JH, Lew DH. Optimal Administration Routes for Adipose-derived Stem Cells
Therapy in Ischaemic Flaps. J Tissue Eng Regen Med 2014;8:596-603.
[35] Park IS, Mondal A, Chung PS, Ahn JC. Prevention of Skin Flap Necrosis by Use of Adipose-derived Stromal Cells with Light-emitting Diode Phototherapy. Cytotherapy. 2015;17:283-92.
[36] Park IS, Chung PS, Ahn JC. Angiogenic Synergistic Effect of Adipose-Derived Stromal Cell Spheroids with Low-Level Light Therapy in a Model of Acute Skin Flap Ischemia. Cells Tissues Organs 2016;202:307-18.
[37] Park IS, Chung PS, Ahn JC, Leproux A. Human Adipose-derived Stem Cell Spheroid Treated with
Photobiomodulation Irradiation Accelerates Tissue Regeneration in Mouse Model of Skin Flap Ischemia.
Lasers Med Sci 2017;32:1737-46.
[38] Toyserkani NM, Jensen CH, Andersen DC, Sheikh SP, Sørensen JA. Human and Autologous Adipose-derived Stromal Cells Increase Flap Survival in Rats Independently of Host Immune Response. Ann Plast Surg 2018;80:181-7.
[39] Pak CS, Moon SY, Lee YE, Kang HJ. Therapeutic Effects against Tissue Necrosis of Remote Ischemic
Preconditioning Combined with Human Adipose-Derived Stem Cells in Random-Pattern Skin Flap Rat Models.
J Invest Surg 2021;34:1304-11.
[40] Harder Y, Contaldo C, Klenk J, Banic A, Jakob SM, Erni D. Improved Skin Flap Survival after Local Heat
Preconditioning in Pigs. J Surg Res 2004;119:100-5.
[41] Wang WZ. Investigation of Reperfusion Injury and Ischemic Preconditioning in Microsurgery. Microsurgery
2009;29:72-9.
[42] Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, et al. Transient Limb
Ischemia Induces Remote Ischemic Preconditioning In Vivo. Circulation 2002;106:2881-3.
[43] Krag AE, Hvas AM, Hvas CL, Kiil BJ. Remote Ischemic Preconditioning in Microsurgical Head and Neck
Reconstruction: A Randomized Controlled Trial. Plast Reconstr Surg Glob Open 2020;8:e2591.
[44] Kubulus D, Amon M, Roesken F, Rücker M, Bauer I, Menger MD. Experimental Cooling-induced Preconditioning Attenuates Skin Flap Failure. Br J Surg 2005;92:1432-8.
[45] Rhodius P, Haddad A, Matsumine H, Sakthivel D, Ackermann M, Sinha I, et al. Noninvasive Flap
Preconditioning by Foam-Mediated External Suction Improves the Survival of Fasciocutaneous Axial-Pattern
Flaps in a Type 2 Diabetic Murine Model. Plast Reconstr Surg 2018;142:872-83.
[46] Kankam HK, Mehta S, Jain A. Thermal Preconditioning for Surgery: A Systematic Review. J Plast Reconstr Aesthet Surg 2020;73:1645-64.
[47] Mehta S, Rolph R, Cornelius V, Harder Y, Farhadi J. Local Heat Preconditioning in Skin Sparing Mastectomy: A Pilot Study. J Plast Reconstr Aesthet Surg 2013;66:1676-82.
[48] Cro S, Mehta S, Farhadi J, Coomber B, Cornelius V. Measuring Skin Necrosis in a Randomised Controlled
Feasibility Trial of Heat Preconditioning on Wound Healing after Reconstructive Breast Surgery: Study Protocol and Statistical Analysis Plan for the PREHEAT Trial. Pilot Feasibility Stud 2018;4:34.
[49] Mehta S, Cro SC, Coomber B, Rolph R, Cornelius V, Farhadi J. A Randomised Controlled Feasibility Trial to Evaluate Local Heat Preconditioning on Wound Healing after Reconstructive Breast Surgery: The preHEAT Trial.
Pilot Feasibility Stud 2019;5:5.
[50] Hottinger DG, Beebe DS, Kozhimannil T, Prielipp RC, Belani KG. Sodium Nitroprusside in 2014: A Clinical
Concepts Review. J Anaesthesiol Clin Pharmacol 2014;30:462-71.
[51] Ren X, Zhao M, Lash B, Martino MM, Julier Z. Growth Factor Engineering Strategies for Regenerative Medicine Applications. Front Bioeng Biotechnol 2020;7:469.
[52] Jones VM, Suarez-Martinez AD, Hodges NA, Murfee WL, Llull R, Katz AJ. A Clinical Perspective on Adiposederived Cell Therapy for Enhancing Microvascular Health and Function: Implications and Applications for Reconstructive Surgery. Microcirculation 2021;28:e12672.
[53] Russell AL, Lefavor R, Durand N, Glover L, Zubair AC. Modifiers of Mesenchymal Stem Cell Quantity and Quality. Transfusion 2018;58:1434-40.
[54] McIntosh K, Zvonic S, Garrett S, Mitchell JB, Floyd ZE, Hammill L, et al. The Immunogenicity of Human Adiposederived Cells: Temporal Changes In Vitro. Stem Cells 2006;24:1246-53.
[55] Orbay H, Devi K, Williams PA, Dehghani T, Silva EA, Sahar DE. Comparison of Endothelial Differentiation
Capacities of Human and Rat Adipose-Derived Stem Cells. Plast Reconstr Surg 2016;138:1231-41.
[56] Wang WZ, Baynosa RC, Zamboni WA. Update on Ischemia-reperfusion Injury for the Plastic Surgeon: 2011.
Plast Reconstr Surg 2011;128:685-92.
[57] Siemionow M, Arslan E. Ischemia/Reperfusion Injury: A Review in Relation to Free Tissue Transfers.
Microsurgery 2004;24:468-75.
[58] Shin HS, Kim MS, Kim BH, Lim HJ, Kim BC, Lee J. Reconstruction of Mandibular Defects With Bone MarrowDerived Stem Cells in Odontogenic Myxoma. J Craniofac Surg. 2020;31:e236-9.
[59] Naderi N, Combellack EJ, Griffin M, Sedaghati T, Javed M, Findlay MW, et al. The Regenerative Role of Adiposederived Stem Cells (ADSC) in Plastic and Reconstructive Surgery. Int Wound J 2017;14:112-24.